BMY Bristol Myers Squibb
Bristol Myers Squibb earnings company data as of 7:06 PM ET 10/30
- 0 of 1 EPS beats
History
1 period, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 29 Oct | EPS | 1.68 | 1.05 | Miss -37.5% |
| Rev | $12.73B | $13.07B | Beat +2.7% |
Insider trades
Open-market buys and sales by BMY's executives, directors and 10% owners in the last 12 months, from their Form 4s
- None no insider bought on the open market
- $437K sold by 2 insiders outside a trading plan
- $1.9M sold by 1 insider under 10b5-1 plans
-
Cristian Massacesi EVP,Chief Med Offr,Head of DevSale$403K 6,249 shares at $64.57 25% of stakeTraded Sep 9 Filed Sep 10
-
Phil M Holzer SVP and ControllerSale$34K 500 shares at $67.50 2.9% of stakeTraded Aug 25 Filed Aug 26
-
David V Elkins CFOPlanned sale$1.9M 30,000 shares at $61.67 16% of stakeTraded Apr 1 Filed Apr 2
Also filed in the last 12 months, not counted as buying or selling: 49 option exercises, 48 share withholdings for taxes, and 37 other transactions.
SEC filings
Recent issuer filings from EDGAR, 13 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 10-Q | Filing Doc | ||
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| 8-K | 2.02,7.01,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| DEFA14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| DEFA14A | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.